EcoDrugPlus

Trace Amine Associated Receptor 1

Ensembl ID : ENSNFUG00015009379
Gene Symbol: TAAR1
1 Cross references
398 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSNFUG00015009373
Gene Symbol: TAAR1
1 Cross references
393 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSNFUG00015009355
Gene Symbol: TAAR1
1 Cross references
343 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSNFUG00015009403
Gene Symbol: TAAR1
1 Cross references
428 Possible Orthologues:

Transforming Growth Factor, Beta Receptor 1 B

Ensembl ID : ENSNFUG00015012849
Gene Symbol: TGFBR1B
1 Cross references
204 Possible Orthologues:

Transient Receptor Potential Cation Channel, Subfamily A, Member 1b

Ensembl ID : ENSNFUG00015011643
Gene Symbol: TRPA1B
1 Cross references
200 Possible Orthologues:

Tryptophan 5-Hydroxylase 1-Like

Ensembl ID : ENSNFUG00015004549
Gene Symbol: LOC107381938
3 Cross references
176 Possible Orthologues:

Tryptophan Hydroxylase 1

Ensembl ID : ENSNFUG00015024208
Gene Symbol: TPH1
3 Cross references
207 Possible Orthologues:

Tubulin Alpha 4a

Ensembl ID : ENSNFUG00015014516
Gene Symbol: TUBA4A
3 Cross references
110 Possible Orthologues:

Tubulin Alpha-1c Chain-Like

Ensembl ID : ENSNFUG00015016015
Gene Symbol: LOC107396539
2 Cross references
170 Possible Orthologues:

Tubulin Beta Chain

Ensembl ID : ENSNFUG00015002211
Gene Symbol: LOC107379492
3 Cross references
221 Possible Orthologues:

Tubulin Beta Chain-Like

Ensembl ID : ENSNFUG00015022784
Gene Symbol: LOC107385350
2 Cross references
184 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).